China NMPA Product Recall - Hip surgery tools

DePuy International Ltd. (UK) initiated a voluntary recall of its hip surgery instruments, as reported by Johnson & Johnson (Shanghai) Medical Devices Co., Ltd. to the National Medical Products Administration (NMPA) on September 18, 2014. The recall stemmed from a critical manufacturing defect: analysis revealed microcracks in the weld area of the instruments. This flaw could compromise the instrument's structural integrity, leading to reduced strength and an elevated risk of breakage during normal use, posing a potential safety concern during orthopedic hip replacement surgeries.While these instruments held a valid registration certificate (CFDA (Imported) No. 20121102717) for import, Johnson & Johnson confirmed that the specific batches affected by this recall (including models like 962004000 with batch numbers such as OSA-149328, OSA-161157, OSA-181610) were not distributed or sold within the Chinese market. Consequently, the Chinese responsible unit, Johnson & Johnson (Shanghai) Medical Devices Co., Ltd., stated that no further local corrective actions, investigation reports, or implementation plans would be undertaken beyond the initial mandatory notification to the NMPA.The NMPA, operating under its regulatory oversight, requested provincial and municipal food and drug administrations to enhance their supervision and management of similar medical devices to ensure public safety. This incident highlights the global nature of medical device quality control and the importance of prompt reporting, even when affected products do not enter a specific national market. The recall affected regions including Australia, New Zealand, Japan, the UK, Ireland, Russia, Saudi Arabia, Belgium, and South Africa.